105 related articles for article (PubMed ID: 11007514)
21. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies.
Van de Wiele C; Dumont F; Dierckx RA; Peers SH; Thornback JR; Slegers G; Thierens H
J Nucl Med; 2001 Nov; 42(11):1722-7. PubMed ID: 11696645
[TBL] [Abstract][Full Text] [Related]
22. Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.
Hellwig D; Gouverneur E; Schaefer A; Raedle J; Menges M; Kirsch CM; Samnick S
Nuklearmedizin; 2008; 47(5):220-4. PubMed ID: 18852930
[TBL] [Abstract][Full Text] [Related]
23. Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT.
Mozley PD; Stubbs JB; Kim HJ; McElgin W; Chumpradit S; Kung MP; Romaniello G; Kung HF
J Nucl Med; 1995 Jul; 36(7):1322-31. PubMed ID: 7790963
[TBL] [Abstract][Full Text] [Related]
24. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
Newberg AB; Plössl K; Mozley PD; Stubbs JB; Wintering N; Udeshi M; Alavi A; Kauppinen T; Kung HF
J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
[TBL] [Abstract][Full Text] [Related]
25.
Nishii R; Higashi T; Kagawa S; Okuyama C; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
[TBL] [Abstract][Full Text] [Related]
26. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
[TBL] [Abstract][Full Text] [Related]
27. Biodistribution and Radiation Dosimetry for the Tau Tracer
Hsiao IT; Lin KJ; Huang KL; Huang CC; Chen HS; Wey SP; Yen TC; Okamura N; Hsu JL
J Nucl Med; 2017 Sep; 58(9):1498-1503. PubMed ID: 28336780
[No Abstract] [Full Text] [Related]
28. Dosimetry of iodine-123 iodobenzamide in healthy volunteers.
Verhoeff NP; Sokole EB; Stabin M; Hengst D; Kung HF; Van Royen EA; Janssen AG
Eur J Nucl Med; 1993 Sep; 20(9):747-52. PubMed ID: 8223767
[TBL] [Abstract][Full Text] [Related]
29. [Phase 1 clinical study of 123I-IBF, a new radioligand for evaluating dopamine D2 receptor with SPECT (I); biodistribution and dosimetry].
Yonekura Y; Sadato N; Tsuchida T; Uematsu H; Nakamura S; Yamamoto K; Ishii Y
Kaku Igaku; 1999 Feb; 36(2):145-53. PubMed ID: 10213982
[TBL] [Abstract][Full Text] [Related]
30. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.
Mozley PD; Stubbs JB; Kim HJ; McElgin W; Kung MP; Meegalla S; Kung HF
J Nucl Med; 1996 Jan; 37(1):151-9. PubMed ID: 8543985
[TBL] [Abstract][Full Text] [Related]
31. Biodistribution and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine receptor.
Mozley PD; Stubbs JB; Kung HF; Selikson MH; Stabin MG; Alavi A
J Nucl Med; 1993 Nov; 34(11):1910-7. PubMed ID: 8229233
[TBL] [Abstract][Full Text] [Related]
32. Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation.
Brown AK; Fujita M; Fujimura Y; Liow JS; Stabin M; Ryu YH; Imaizumi M; Hong J; Pike VW; Innis RB
J Nucl Med; 2007 Dec; 48(12):2072-9. PubMed ID: 18006619
[TBL] [Abstract][Full Text] [Related]
33. Dosimetry of transmission measurements in nuclear medicine: a study using anthropomorphic phantoms and thermoluminescent dosimeters.
Almeida P; Bendriem B; de Dreuille O; Peltier A; Perrot C; Brulon V
Eur J Nucl Med; 1998 Oct; 25(10):1435-41. PubMed ID: 9818285
[TBL] [Abstract][Full Text] [Related]
34. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans.
Nye JA; Schuster DM; Yu W; Camp VM; Goodman MM; Votaw JR
J Nucl Med; 2007 Jun; 48(6):1017-20. PubMed ID: 17504867
[TBL] [Abstract][Full Text] [Related]
36. Human biodistribution and dosimetry of the SPECT benzodiazepine receptor radioligand iodine-123-iomazenil.
Dey HM; Seibyl JP; Stubbs JB; Zoghbi SS; Baldwin RM; Smith EO; Zubal IG; Zea-Ponce Y; Olson C; Charney DS
J Nucl Med; 1994 Mar; 35(3):399-404. PubMed ID: 8113883
[TBL] [Abstract][Full Text] [Related]
37. Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers.
Ribeiro MJ; Ricard M; Bourgeois S; Lièvre MA; Bottlaender M; Gervais P; Dollé F; Syrota A
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):952-8. PubMed ID: 15841376
[TBL] [Abstract][Full Text] [Related]
38. Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET.
Laforest R; Dehdashti F; Lewis JS; Schwarz SW
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):764-70. PubMed ID: 15785955
[TBL] [Abstract][Full Text] [Related]
39. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest.
Maddahi J; Czernin J; Lazewatsky J; Huang SC; Dahlbom M; Schelbert H; Sparks R; Ehlgen A; Crane P; Zhu Q; Devine M; Phelps M
J Nucl Med; 2011 Sep; 52(9):1490-8. PubMed ID: 21849402
[TBL] [Abstract][Full Text] [Related]
40. Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand
Lizana H; Johansson L; Axelsson J; Larsson A; Ögren M; Linder J; Halldin C; Varrone A; Mo SJ
J Nucl Med; 2018 Aug; 59(8):1275-1280. PubMed ID: 29348315
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
